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The expression of 
 
Staphylococcus aureus
 
 adhesins in 
 
Lactococcus lactis
 
 identified clumping 
factor A (ClfA) and fibronectin-binding protein A (FnBPA) as critical for valve colonization 
in rats with experimental endocarditis. This study further analyzed their role in disease 
evolution. Infected animals were followed for 3 d. ClfA-positive lactococci successfully 
colonized damaged valves, but were spontaneously eradicated over 48 h. In contrast, FnBPA-
positive lactococci progressively increased bacterial titers in vegetations and spleens. At 
imaging, ClfA-positive lactococci were restricted to the vegetations, whereas FnBPA-
positive lactococci also invaded the adjacent endothelium. This reflected the capacity of 
FnBPA to trigger cell internalization in vitro. Because FnBPA carries both fibrinogen- and 
fibronectin-binding domains, we tested the role of these functionalities by deleting the 
fibrinogen-binding domain of FnBPA and supplementing it with the fibrinogen-binding 
domain of ClfA in cis or in trans. Deletion of the fibrinogen-binding domain of FnBPA did 
not alter fibronectin binding and cell internalization in vitro. However, it totally abrogated 
valve infectivity in vivo. This ability was restored in cis by inserting the fibrinogen-binding 
domain of ClfA into truncated FnBPA, and in trans by coexpressing full-length ClfA and 
truncated FnBPA on two separate plasmids. Thus, fibrinogen and fibronectin binding could 
cooperate for 
 
S. aureus
 
 valve colonization and endothelial invasion in vivo.
 
Staphylococcus aureus
 
 carries a wealth of patho-
genic factors including surface adhesins that
promote tissue colonization, and secreted exo-
enzymes and toxins that promote tissue dam-
age and distant diseases (1–4). In addition, in-
fections caused by 
 
S. aureus
 
 frequently relapse
in spite of adequate antibiotic treatment. Such
persistence often remains unexplained. One
possible cause relies on their ability to survive
inside host cells. 
 
S. aureus
 
 can invade a variety
of nonprofessional phagocytes in vitro, such as
epithelial cells (5–7), fibroblasts (8), osteoblasts
(9), and endothelial cells (10–12). After inter-
nalization, 
 
S. aureus
 
 may either persist, escap-
ing host defenses and antibacterial agents, or
multiply and further disseminate. This behav-
ior is orchestrated by global regulators such as
 
agr
 
, 
 
sar
 
, and perhaps 
 
sigB
 
, all of which sense en-
vironmental modifications, such as bacterial
density, and may or may not trigger the secre-
tion of toxins and hemolysins that lyse the host
cells and allow the bacteria to propagate (13–
16). Thus, invading host cells might not only
provide a therapeutic sanctuary, but also be
part of a subtle hide-and-seek strategy, as ob-
served with enteric bacteria (17). However,
the in vivo relevance of this concept is not
demonstrated.
Infective endocarditis is a good model to
study 
 
S. aureus
 
 pathogenesis. It implicates step-
wise valve colonization by circulating bacteria,
local settling and invasion, and the eventual
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dissemination to distant organs. Using this model, we dem-
onstrated that both fibrinogen and fibronectin binding were
critical to initiate experimental endocarditis (18). Specifi-
cally, the 
 
S. aureus
 
 fibrinogen-binding protein A (clumping
factor A [ClfA]; reference 19) and fibronectin-binding pro-
tein (FnBPA) A (20) were individually expressed in the less
pathogenic 
 
Lactococcus lactis
 
, and the recombinants were
tested for augmented infectivity. Both determinants in-
creased the capacity of lactococci to colonize damaged valves
in rats with catheter-induced sterile vegetations by several
orders of magnitude (18).
We further investigated the contribution of fibrinogen
and fibronectin binding to disease progression. Although
both ClfA and FnBPA promoted valve colonization, they
also provoked very different disease evolutions. Rats infected
with ClfA-positive lactococci tended to spontaneously steril-
ize their valves over time. In contrast, rats infected with Fn-
BPA-positive lactococci developed progressive infections
and suffered clinical signs of sepsis. This invasive phenotype
correlated with the capacity of FnBPA-positive recombi-
nants, but not ClfA-positive recombinants, to invade endo-
thelial cells in vitro and in vivo.
Because FnBPA carries both fibronectin- and fibrinogen-
binding domains (21), we further studied their individual
importance first by deleting the fibrinogen-binding domain
from FnBPA, in the form of a truncated protein, and then by
supplementing it in cis and in trans with the fibrinogen-
binding domain of ClfA. The deletion of the fibrinogen-
binding domain of FnBPA did not decrease its abilities to
bind to fibronectin and trigger cell invasion in vitro. How-
ever, it totally abrogated its capacity to promote valve infec-
tion and invasion in vivo. This loss of function could be re-
stored in cis by inserting the fibrinogen-binding domain of
ClfA into the truncated FnBPA. Moreover, it could also be
restored in trans by coexpressing truncated FnBPA with full-
length ClfA, which does not confer invasion and persistence,
as two separate proteins. Thus, fibrinogen and fibronectin
binding could cooperate in vivo to promote valve coloniza-
tion and invasion.
 
RESULTS
Evolution of experimental endocarditis
 
Groups of rats were challenged with 10 times the 80% infec-
tive dose (ID
 
80
 
) of each of the test organisms (18). The dy-
namics of infection were followed over 3 d (Fig. 1). After
2 h, all the animals had similar vegetation bacterial titers irre-
spective of the infecting organism. This was in accordance
with previous work in experimental endocarditis, indicating
that a challenge with large inocula could overcome the dif-
ferences because of bacterial adherence in early valve coloni-
zation (18, 22–25). Subsequently, the disease evolution var-
ied depending on the organisms. Control lactococci carrying
an empty vector were poorly infective and were progres-
sively cleared from both the valves and the spleens. ClfA-
positive lactococci were more prone to colonize the valves
(18), but were also cleared from the animals. In sharp con-
trast, FnBPA-positive lactococci persisted and expanded at
both anatomical sites, thus imitating the dynamics of experi-
mental endocarditis induced by the well-characterized clini-
cal isolate of 
 
S. aureus
 
 P8 (see Table I), depicted in Fig. 1.
Clinical signs varied with the organisms as well. All the rats
infected with the negative control or the ClfA-positive lac-
tococcus had a normal aspect at days 2 and 3. In contrast, rats
infected with the FnBPA-positive lactococcus or 
 
S. aureus
 
P8 remained curled up in their cage with ruffled fur.
 
Immunohistology of cardiac valves
 
The different disease evolutions induced by ClfA- and Fn-
BPA-positive lactococci were not caused by differences in
Figure 1. Evolution of valve infection in rats with experimental 
endocarditis caused by various test organisms. Bacterial densities in 
the vegetations (A) and spleens (B) are indicated. Groups of rats with catheter-
induced aortic vegetations were challenged with 10 times the ID80 of the 
test bacteria and killed at various time points over a period of 3 d. Each 
data point represents the mean  SD of vegetation bacterial titers of 
8–10 animals. Bacterial strains are indicated on the figure and described 
in Table I. L. lactis pIL253 carried an empty expression vector (reference 
18). L. lactis ClfA () and L. lactis FnBPA () carried a vector expressing 
ClfA and FnBPA, respectively (references 18, 47). S. aureus P8 was used as 
a positive control. Rats infected with L. lactis FnBPA () worsened both 
vegetation bacterial titers and spleen infection (median [range] bacteria/
gram of spleen  3.04 [1.92–3.3], 1.8 [1.29–3.21], 1.92 [1.41-3.2], and 1.84 
[1.08–3.21] at 12, 24, 48, and 72 h, respectively) over time. In contrast, rats 
infected with either L. lactis pIL253 or L. lactis ClfA () underwent sponta-
neous clearing of the infection (* and **, P  0.01).
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growth rates in vitro or the loss of the expression vector in
vivo (18). Moreover, immunohistology of the cardiac lesions
indicated that both 
 
clfA
 
 and 
 
fnbA
 
 were expressed at the in-
fected site (Fig. 2). However, ClfA-positive lactococci were
strictly confined to the fibrin platelet vegetation meshwork
(Fig. 2 A) and were absent from the neighboring endothe-
lium (Fig. 2 B), whereas FnBPA-positive lactococci were
detected both in the vegetation (Fig. 2 D) and colocalizing
with the adjacent endothelium (Fig. 2 E). Fig. 2 (C and F)
assesses the integrity of the endothelial lining as detected by
anti–von Willebrand antibodies.
Conversely, deleting the 
 
fnbA
 
 and 
 
fnbB
 
 genes from wild-
type 
 
S. aureus
 
 Cowan I gave the reverse picture. Parent 
 
S.
aureus
 
 Cowan I was detected both in the vegetation and the
adjacent endothelium, whereas strain DU5883, an 
 
fnbA
 
/
 
fnbB
 
–deficient mutant of 8325-4 was confined to the vegeta-
tion (not depicted). Thus, the association between bacteria
and the endothelium correlated with the expression of fi-
bronectin-binding proteins on their surface.
 
Imaging by electron microscopy (EM)
 
Colocalization with the neighboring endothelium could be
caused by surface-bound and/or internalized bacteria. To
solve this issue, valves infected with FnBPA-positive lacto-
cocci were scanned by light microscopy, and areas contain-
ing bacteria were processed for EM. Various stainings were
used. Fig. 3 A (osmium staining) depicts an endothelial cell
harboring both surface-attached and apparently internalized
lactococci. Surface-attached lactococci displayed a thick,
dark-stained outershell, whereas lactococci in the cytoplasm
were surrounded by a clear halo. This halo could result ei-
ther from free space between noninternalized bacteria that
Figure 2. Immunohistochemistry of the vegetations and neighbor-
ing valve endothelium in rats infected with either ClfA-positive (L. 
lactis) or FnBPA-positive (L. lactis) recombinant lactococci. Animals 
were killed 24 h after inoculation, and tissues were processed as described 
previously. Expression of the recombinant adhesins was detected with either 
anti–ClfA F(ab)’2 fragments (A and B) or anti–FnBPA F(ab)’2 fragments 
(D and E). C and F were labeled with anti–von Willebrand primary antibodies 
to determine the presence of the endothelial layer. Fluorescence indicates 
the presence of bacteria (A, D, and E) and endothelial cells (C and F). Com-
parison between Gram’s stains and immunodetected bacteria indicated 
that all visible microorganisms expressed their recombinant gene (unpub-
lished data; SMC, smooth muscle cells; L, vascular lumen).
Figure 3. Electron microscopy imaging of the valve endothelium 
adjacent to infected vegetations. Rats were infected with either Fn-
BPA-positive recombinant lactococci (top) or S. aureus Cowan I (bottom). 
(A) Presentation of an osmium staining of an endothelial cell sandwiched 
by the vascular lumen (L) on top and the basal lamina (BL) on bottom. 
Lactococci adherent to the endothelial cell are surrounded by a dark halo, 
whereas lactococci inside the cell are surrounded by a clear halo. (B) A PAS 
staining of the same cell. The fact that the clear halo surrounding the 
intra-endothelial lactococci takes PAS indicates that it consists of extra-
cellular polysaccharides. A mitochondria (M) is observed. (C) An osmium 
staining of an intracellular dividing lactococcus. The endothelial plasma 
membrane (arrow) and mitochondria (M) are indicated. (D) Tannic acid 
staining that helps distinguish between the presence and the absence 
of intracellular membranes. The membrane lining mitochondria and intra-
cellular vesicles is clearly apparent, whereas no clear membrane surrounds 
the internalized lactococcus (arrows). E–G depict S. aureus Cowan I at 
various infection stages: (E) adherence and invasion; (F and G) intracellular 
location; and (H) cell disruption. E, G, and H are stained by osmium stain-
ing and F is stained by tannic acid (arrows, plasma membranes; N, nucleus; 
L, vascular lumen; BL, basal lamina). Magnification was 8,000–16,000.
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were located within invaginations of the cell membrane, or
from internalized bacteria that escaped staining of their out-
ermost polyanionic layers (e.g., teichoic acids and/or exo-
polysaccharides). Fig. 3 B shows that the halos around in-
tracellular lactococci could be stained with periodic acid
(PAS) and were thus compatible with anionic polymers. Fig.
3 C shows mitochondria positioned in the vicinity of an in-
ternalized FnBPA-positive lactococcus at a higher magnifi-
cation. Fig. 3 D is a tannic acid stain that helped determine
whether the intracellular bacteria were surrounded by a
membrane or not. No clear membrane structure was ob-
served. Collectively, these observations indicate that the
colocalization of the bacteria with the endothelial cells did
not result from coincidental bacteria–endothelium superpo-
sition, but rather from genuine bacterial internalization.
Moreover, the absence of a membrane lining around inter-
nalized bacteria suggests the possibility of membrane disrup-
tion after bacterial entry.
A similar analysis was performed with 
 
S. aureus
 
 Cowan I.
In contrast to lactococci, which were mostly observed in in-
tact endothelial cells, 
 
S. aureus
 
 generated a continuum from
bacterial internalization to microbe-related cell lysis (Fig. 3,
E–H). This most likely resulted from the expression of spe-
cific staphylococcus virulence factors, such as hemolysins. 
A semiquantitative evaluation of internalization was as-
sessed in animals killed between 12 and 48 h after inoculation.
Two rats were used for each time point. Semithin sections
from five to nine specimens from each animal’s valves were
examined by light microscopy, and specimens containing bac-
teria were processed for EM by another investigator. Samples
could not be formally blinded because the morphological
characteristics of the bacteria allowed identification of the ma-
terial. With FnBPA-positive lactococci, the proportion of
valve samples demonstrating internalized bacteria progres-
sively increased from 0% at 12 h to 4% at 24 h to 20% at 48 h.
However, with 
 
S. aureus
 
 Cowan I, the proportion of positive
blocs paradoxically decreased from 60% at 18 h to 12% at 24 h.
Thus, although both organisms increased their vegetation
bacterial titers over time (Fig. 1), internalization of FnBPA-
positive lactococci increased from low to high numbers, and
the internalization of bona fide staphylococci decreased from
relatively high to low numbers. This is compatible with
staphylococcal-induced endothelial destruction that was not
apparent in lactococci-infected samples (Fig. 3, E–H).
 
Invasion of endothelial cells in vitro
 
The series of strains used in animals were further tested for
their ability to invade cultured human umbilical vein endo-
thelial cells
 
 (
 
HUVECs) in vitro. Fig. 4 presents the results of
internalization as tested by an antibiotic–lysostaphin protec-
tion assay (black bars) and by flow cytometry (gray bars), as
well as by confocal microscopy (right). The production of fi-
bronectin-binding proteins was necessary and sufficient to
mediate endothelial internalization of both recombinant lac-
tococci and staphylococci. This supported the in vivo mor-
phological observations.
 
Implication of the fibrinogen- and fibronectin-binding 
domains of FnBPA in infection
 
FnBPA was shown to bind both fibronectin and fibrinogen
(21). The role of these two functionalities was studied in lac-
tococci expressing either a truncated FnBPA, lacking its fi-
brinogen-binding domain, or the truncated FnBPA supple-
mented in cis or in trans with the fibrinogen-binding
domain of ClfA (Fig. 5 A).
Deletion of the fibrinogen-binding domain of FnBPA
abrogated binding to fibrinogen, but not binding to fi-
bronectin and internalization into endothelial cells (Fig. 5 B).
However, it completely abrogated its ability to promote car-
diac valve infection and persistence in vivo. This loss of
function was restored by supplementing the truncated Fn-
BPA in cis with the fibrinogen-binding domain of ClfA (Fig.
5 B). In addition, it was also restored by supplementing the
truncated FnBPA in trans, via the expression of whole ClfA
on a separate plasmid. Fig. 6 depicts the dynamics of valve
infection in rats inoculated with the cis- and trans-recombi-
nants. The two supplemented constructs could engender a
persistent and progressive infection. In contrast, lactococci
expressing truncated FnBPA or ClfA alone were either non-
infective or nonpersistent, respectively. Note that the trans-
recombinant grew slower than its cis-counterpart on the
valves. This correlated with a 10–20% slower growth rate of
the cis-recombinant in vitro, which we attributed to the
concurrent replication of two independent plasmids.
 
DISCUSSION
 
We previously showed that 
 
S. aureus
 
 ClfA and FnBPA pro-
moted the colonization of damaged valves in rats with ex-
Figure 4. Internalization of staphylococci and lactococci producing 
or not producing fibronectin-binding proteins by cultured HUVECs. 
Internalization was measured both by a penicillin–lysostaphin protection 
assay (black bars) and by flow cytometry (gray bars; reference 8). The 
results present the mean  SD of three independent experiments and are 
expressed as a percentage of S. aureus Cowan I internalization. Bacterial 
strains are indicated at the bottom (Table I). The right panel is a magnified 
view of an internalized lactococcus as detected by confocal microscopy.
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perimental endocarditis (18, 25). However, their role in dis-
ease progression was unknown. The present results indicate
that the two factors conferred complementary features in the
infection process. ClfA promoted early valve colonization,
but not persistence, whereas FnBPA promoted both coloni-
zation and persistence, resulting in clinical symptoms reminis-
cent of genuine 
 
S. aureus
 
 infection. This difference in disease
evolutions was related to the unique ability of FnBPA-pro-
ducing lactococci to invade endothelial cells both in vitro
and in vivo. FnBPA can trigger active internalization into a
number of eukaryotic cells (6–12). In the present experi-
ments, it allowed lactococci to expand not only in the vege-
tations, which are essentially devoid of host defense mecha-
nisms (26, 27), but also in the spleen, which is notoriously
rich in professional phagocytes. Thus, FnBPA must have af-
forded protection against these cellular host defenses.
An intracellular location would provide such a protec-
tion. Lactococci overtly exposed to vegetation components
would be the target of platelet microbicidal proteins (28), to
which the lactococcus used in this study is susceptible (un-
published data). Likewise, lactococci trapped in the spleen
would be eliminated by phagocyte-induced killing. Accord-
ingly, both parent and ClfA-positive lactococci, which were
not internalized in vitro or in vivo, were rapidly eradicated
from the animals regardless of their abilities to initially colo-
nize damaged endothelia. In contrast, FnBPA-producing
lactococci, which were internalized, could survive and pro-
liferate. Indeed, EM imaging consistently revealed the pres-
ence of dividing lactococci inside endothelial cells (Fig. 3,
A–D), thus underlying the permissive nature of this particu-
lar environment. This is a salient example of host cell hijack-
ing mediated by a highly specialized bacterial adhesin. It is
reminiscent of 
 
Listeria
 
 species, in which the heterologous ex-
pression of 
 
L. monocytogenes 
 
Internalin A in nonpathogenic
 
L. innocua
 
 conferred the ability to invade epithelial cells (29).
This observation raises multiple questions regarding these
complex bacteria–host interactions. 
 
S. aureus
 
 carries several
Figure 5. FnBPA and ClfA constructs expressed in lactococci and 
used to test the function of specific domains in vitro and in vivo. A 
presents the nucleotide map of the constructs and B presents the resulting 
phenotypes. The Wall anchor construct contained only the leader sequence 
(L) and the wall (W), and membrane (M)-anchoring domains of whole FnBPA. 
The CD construct contained the leader sequence and the wall-anchoring 
domains bracketing the C and D regions involved in fibronectin binding. 
FnBPA, the whole protein containing the A and B additional domains 
(reference 18); ClfA, the whole S. aureus clumping factor A cloned and 
expressed in lactococci (R, repeats; reference 47). Construct A-ClfA-CD-FnBPA 
is a chimera used for cis-supplementation of the construct of the trun-
cated FnBPA (construct CD) with the fibrinogen-binding domain of ClfA. 
Trans-supplementation was achieved by coexpressing truncated FnBPA 
(construct CD) with whole ClfA on separate plasmids. The top panel of B 
presents the vegetation and spleen bacterial densities in rats challenged 
intravenously with a bacterial number inoculum equivalent to the ID80 of 
recombinant lactococci expressing whole FnBPA (i.e., 105 CFU) and killed 
after 24 h (Fig. 1). Each dot represents one individual animal. Mean bacterial 
densities were notably higher (P  0.01) in rats infected either with lacto-
cocci expressing whole FnBPA or with lactococci expressing the cis- or the 
trans-supplemented constructs. The bottom panel of B depicts the in vitro 
adherence and internalization phenotype of the various constructs. ClfA-
expressing lactococci were used as a control. , optical densities (for bind-
ing) or bacterial counts (for internalization) less than or equal to the back-
ground; , values greater than or equal to the background.
Figure 6. Evolution of valve infection in rats challenged with lac-
tococci expressing truncated FnBPA supplemented or not supple-
mented with the fibrinogen-binding domain of ClfA in cis or in 
trans. Recombinants expressing either whole ClfA or truncated FnBPA 
(construct CD) are depicted as controls. Each data point represents the 
mean  SD (n  5 individual rats). The slower growth rate of the trans 
versus cis construct in rats mirrored its slower growth rate in vitro, 
because of the simultaneous presence of two separate plasmids. Other 
details are the same as in Fig. 1.
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adhesins that can mediate internalization into eukaryotic
cells. These include FnBPA (6–12) and FnBPB (30), and the
loosely surface-attached extracellular adherence protein (31).
In contrast, FnBPs from coagulase-negative staphylococci do
not promote cell internalization (32). The difference is sup-
posedly related to structural variations between the two
kinds of adhesins. Fibronectin bound on the surface of 
 
S. au-
reus
 
 forms multimers that promote interaction with integrins,
whereas fibronectin bound on the surface of coagulase-neg-
ative staphylococci does not form such structures (32).
Hence, internalization must be an important addition that al-
lows successful infection by 
 
S. aureus
 
.
Once internalized, 
 
S. aureus
 
 are equipped to lyse the host
cells via quorum-sensing regulated production of hemolysins
and toxins (33). Although only semiquantitative, the in vivo
EM data presented here support this scenario (33, 34). Over
time, the number of endothelial cells containing bacteria in-
creased in rats infected with FnBPA-positive lactococci,
whereas it decreased in rats infected with 
 
S. aureus
 
. This cor-
related with 
 
S. aureus
 
–mediated endothelial destruction, as
observed by EM. Therefore, once inside the cells, 
 
S. aureus
 
 is
not mere circumstantial parasites, but highly specialized
pathogens that take advantage of the eukaryotic milieu to
switch between hiding and dissemination strategies.
FnBPA is a multifunctional adhesin that affords binding to
several matrix proteins, including fibronectin (domains B, C,
and D; references 35–37), fibrinogen (domain A; reference
21), and elastin (38). Binding to fibronectin triggers internal-
ization via a “zipper mechanism,” requiring eukaryotic cell-
mediated processes (39). It is followed by profound changes in
the endothelial cell metabolism, including the expression in-
terleukins (IL-1, IL-6, and IL-8), cell adhesion molecules
(ICAM-1 and VCAM-1), and tissue factor (40). Eventually,
the cells might undergo apoptosis (41). Binding to fibrinogen,
on the other hand, is not required for internalization in vitro
(35) Thus, the question arose as to whether the fibrinogen-
binding domain (i.e., domain A) of FnBPA was required for
valve infection in vivo, or whether fibronectin binding alone,
afforded by domains B, C, and D, was sufficient for both valve
colonization and invasion. The present results unequivocally
show that FnBPA needed both binding capacities.
The fibronectin-binding property is partitioned into 11
binding motifs, which may independently bind to a series of
consecutive F1 modules carried by the NH
 
2
 
-terminal “N29”
domain of fibronectin (20, 39, 42). The 11 binding motifs
have varying affinities for their ligand. However, they are re-
cruited to increase binding strength (39, 42–44). The present
observation extends this notion to in vivo domain interac-
tions. Binding to both fibrinogen and fibronectin was re-
quired for the sequential colonization and invasion of dam-
aged valves. Moreover, the fibrinogen-binding domain of
FnBPA could be supplemented both in cis and in trans by its
homologous domain in ClfA. Thus, functional domains are
interchangeable and can cooperate even when located on
separate polypeptides. 
 
S. aureus
 
 is particularly well equipped
in surface adhesins (45). Hence, associating them in various
combinations may help target the organism to different ana-
tomical sites. This may explain the notorious versatility of S.
aureus infections (1), as well as the difficulty in studying staph-
ylococcal pathogenesis using single-gene inactivated mutants.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains used in this
study are described in Table I. L. lactis cremoris was grown at 30C in M17
medium (Oxoid) supplemented with 0.5% glucose (46). S. aureus was
Table I. Bacterial strains and used in this study
Plasmid/strain Properties Origin/reference
L. lactis cremoris 1363 Prophage-cured L. lactis cremoris strain (52)
L. lactis ClfA-positive L. lactis strain expressing S. aureus ClfA (47)
L. lactis FnBPA-positive L. lactis strain expressing S. aureus FnBPA (18)
L. lactis LPXTG
L. lactis strain expressing the cell wall-anchoring domain
of S. aureus FnBPA (amino acid 881–1018) This study
L. lactis CD
L. lactis strain expressing domains C and D of S. aureus 
FnBPA (amino acid 606–1018) This study
L. lactis A-ClfA plus
CD-FnBPA
L. lactis strain expressing domain A of S. aureus ClfA
(amino acid 1-502) fused to domains C and D of
S. aureus FnBPA (amino acid 606–1018)
This study
(used for cis-supplementation)
L. lactis ClfA plus 
CD-FnBPA
L. lactis strain expressing whole S. aureus ClfA (as in L. lactis
ClfA-positive, above) plus domains C-D of S. aureus 
FnBPA (amino acid 606–1018) 
This study
(used for trans-supplementation)
S. aureus Newman ClfA-producing strain (19)
S. aureus Cowan I FnBPA and FnBPB-producing strain ATCC 12598
S. aureus 8325-4
Prophage-cured ATCC strain
low production of FnBPA and FnBPB (53)
S. aureus DU5883 FnBPA and FnBPB-negative mutant (54)
ATCC, American Type Culture Collection.
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grown at 37C in Mueller-Hinton or tryptic soy medium (Difco Laborato-
ries). Escherichia coli was grown at 37C in LB medium (Difco). Whenever
appropriate, either 5 g/ml erythromycin and/or 5 g/ml chlorampheni-
col (L. lactis), 500 g/ml erythromycin, or 20 g/ml chloramphenicol (E.
coli) were used as selective agents. Bacterial stocks were kept at –70C in liq-
uid medium supplemented with 10% (vol/vol) glycerol.
Expression of staphylococcal adhesins in lactococci and construction
of truncated FnBPA proteins. The staphylococcal clfA and fnbA genes
were amplified from chromosomal DNA of S. aureus Newman and S. aureus
8325-4, respectively (Table I), ligated at the BamHI site of the pOri23 vec-
tor, and expressed in L. lactis as described previously (18, 47). FnBPA con-
tains domains binding both fibrinogen (region A) and fibronectin (regions
B, C, and D; references 21, 35, 36). Deletion of internal binding domains
took advantage of a previously described inverse PCR strategy (35). Plasmid
pOri23-FnBPA, carrying the whole fnbA gene, was used as a template (18).
To delete regions A and B, encompassing the fibrinogen-binding region
(21), a construct named “CD” was generated by using a backward (NH2-
terminal) oriented primer starting at bp 228 of fnbA (5	-TA CGA TCG
GAA TCA AAT CCA ATT GAC TTT GAA-3	; Microsynth) and a for-
ward (COOH-terminal oriented) primer starting at bp 1933 of the gene
(5	-GA CGA TCG TGC TGC AGC TTC TTT GTC TTG T-3	). Both
primers carried a PvuI (in bold) site at the 5	-end, permitting religation in
new pOri-CD (Table I) that missed amino acid 37–605 (bp 229–1932) of
FnBPA (Fig. 5). To delete the entire ABCD domains—encompassing both
fibrinogen and fibronectin-binding regions (21, 35)—a construct was gen-
erated by using a backward (NH2-terminal oriented) primer starting at bp
228 (5	-TA CGA TCG CCG ACA CCA GAA GTA CCA AGT-3	) and
a forward (COOH-terminal oriented) primer starting at bp 2761 of fnbA
(5	-GA CGA TCG TGC TGC AGC TTC TTT GTC TTG T-3	). The
resulting ABCD-FnBPA was deleted from amino acid 37 to 880 (bp 228–
2761; Fig. 5). Both truncated proteins contained their NH2-terminal leader
and their COOH-terminal wall-anchoring sequences. Expand long tem-
plate PCR system (Roche Diagnostics) was used according to the manufac-
turer’s instructions to amplify the DNA-encoding parts of the fnbA gene
and the plasmid backbone. The following conditions were applied for 25
cycles: 95C for 30 s, 60C for 30 s, and 68C for 10 min. Amplified DNA
was purified using the Qiaquick PCR purification kit (QIAGEN), digested
with PvuI (Roche Diagnostics), and self-ligated with T4 DNA ligase. The
plasmids were expanded in E. coli and transferred into L. lactis as previously
described (18).
Cis- and trans-supplementation with the fibrinogen-binding domain
of ClfA. For cis-supplementation, a chimera protein containing the A do-
main of ClfA (bp 138–164 and amino acid 1–502; responsible for fibrinogen
binding), and the C and D domains of FnBPA (bp 1933–2761 and amino
acid 606–1018; responsible for fibronectin binding), as well as its wall-
anchoring domain (bp 2761–3174), was constructed. The cloning strategy
was as follows. The two primers 5	-TAG GAT CCG AAA ATA GTG TTA
CGC AAT CT-3	 and 5	-TAA GGC CTT GGT TTA TCG ATA CCG
TCA -3	 were used to amplify the A domain of ClfA, and the two primers
5	-CAA GGC CTG AAT CAA ATC CAA TTG ACT TTG AA-3	 and
5	-GCG CGT CGA CGC TTA CTT CAT ATA ATT TAT GAA-3	
were used to amplify the C, D, W, and M domains of FnBPA (Mi-
crosynth). Restriction sites for BamHI, StuI, and SalI are shown in bold.
Both fragments were cloned in pGEM-T-easy as instructed by the manu-
facturer (Promega). After expansion in E. coli and extraction using standard
techniques (48), the fragments were fused in pGEM-T-easy using the PvuI
restriction sites, and the nucleotide sequence of the fusion protein was veri-
fied. The new fragment encompassing the A domain of ClfA fused to the
C, D, W, and M domains of FnBPA was then cloned between the BamHI
and SalI restriction sites of the pOri23 expression vector and transformed
into L. lactis as described previously (18, 47).
For trans-supplementation, whole ClfA and truncated FnBPA were ex-
pressed simultaneously on separate plasmids. The second expression plasmid
was constructed by replacing the erythromycin-resistant gene of pOri23-
CD with a chloramphenicol-resistant gene. The erythromycin-resistant
gene was removed by digestion with ScaI and HpaI. The chloramphenicol-
resistant gene was amplified from plasmid pVE3702 (provided by Alexandra
Gruss, Laboratoire de Génétique Appliquée, Institut de la Recherche
Agronomique, Jouy-en-Josas, France). The forward primer (5	-TTT AGT
ACT TTT AGG AGG CAT ATC AAA TGA AC-3	; Microsynth) started
at bp 2011 and contained a ScaI site (indicated in bold). The backward
primer (5	-AAT GTT AAC TAA AAA GTA CAG TCG GCA TTA
TCT C-3	) started at codon 2706 and contained a HpaI site (indicated in
bold). The amplicon was double digested with ScaI and HpaI, and ligated
into the ScaI–HpaI-digested pOri23-CD, generating pOriCm-CD. This
plasmid was transformed into L. lactis harboring pOri-ClfA, which expresses
ClfA (Table I; references 18, 47). The transformants were selected on eryth-
romycin- and chloramphenicol-containing plates. All 10 (100%) double-
resistant transformants expressed both ClfA and truncated FnBPA function-
ally. The double transformant grew 10–20% slower in liquid medium
(containing the selective antibiotics) than either the parent or the single pos-
itive pOri-ClfA or pOriC-CD L. lactis.
Antibodies. Anti-ClfA F(ab)	2 (19) were prepared as previously de-
scribed. Peptides corresponding to the FnBPA residues 479–493 (IQNNK-
FEYKEDTIKE) were conjugated to KLH and used to immunize rabbits
(Eurogentec). F(ab)	2 fragments were further prepared from rabbit immune
sera using the ImmunoPure F(ab)	2 preparation kit (Pierce Chemical Co.)
according to the manufacturer’s instructions. Anti–von Willebrand factor
antibodies were obtained from Sigma-Aldrich.
Experimental endocarditis in rats. The permission for experimenta-
tion on living animals regarding the present work was granted by the State
Veterinary Office of the “Canton de Vaud” (permission 879.39). Sterile
aortic vegetations were produced in female Wistar rats as described previ-
ously (49). 24 h after catheterization, groups of 8–10 rats were challenged
intravenously with an inoculum 10 times greater than ID80. Groups of ani-
mals were killed at various time points thereafter. Quantitative valve and
spleen cultures were performed as previously described (18, 22, 24, 25).
Lactococcal recombinants were plated on both erythromycin-containing
and erythromycin-free agar to ascertain the presence of the expression vec-
tor encoding the staphylococcal genes (18, 47). When two expression plas-
mids were used, bacteria were plated on agar containing both erythromycin
and chloramphenicol. Bacterial densities in the vegetations were expressed
as the mean of log10 CFU/gram of tissue  SD. The limit of detection was
2 log10 CFU/gram of tissue. Rats with sterile valve cultures were consid-
ered uninfected. Differences between mean vegetation bacterial densities
were evaluated by one-way analysis of variance, and pair-wise differences
between the means of groups were determined by the t test with the Bon-
ferroni correction. Differences were considered important when P 
 0.05
by use of two-tailed significance levels.
Immunohistochemistry. Rats with sterile aortic vegetations were inoc-
ulated as described in the previous paragraph and killed 24 h later. Cardiac
vegetations were excised and rapidly frozen in 2-methylbutane cooled in
liquid nitrogen. Vegetations were then included in OCT medium (Leica
Instruments) and cryostat sectioned at an 8-m thickness. The sections
were rinsed in PBS and incubated in buffer containing 3% BSA before an
O/N incubation in the presence of anti–ClfA F(ab)	2 or anti–FnBPA
F(ab)	2 fragments diluted 1:200 in PBS. Primary antibodies were detected
using goat anti–rabbit F(ab)	2 immunoglobulins labeled with FITC (Pierce
Chemical Co.). Sections were then rinsed in PBS, stained with Evan’s blue,
and photographed under a microscope with film (Tmax 400; Kodak).
Electron microscopy. Inoculation and killing was performed as de-
scribed in the Immunohistochemistry section. Small tissue fragments (1
mm) were fixed by immersion at 4C for 2 h in 2% glutaraldehyde/0.1 M
Sörensen phosphate buffer, washed, postfixed with 1% OsO4 at room tem-
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perature for 1 h, dehydrated through graded concentrations of acetone, and
embedded in Epon-Araldite. Because endocarditis is a heterogeneous infec-
tion, semithin sections were first screened for the presence of bacteria. Ul-
trathin sections were cut from the outer part of the tissue samples, stained
with lead citrate and observed using an electron microscope. To reveal car-
bohydrates, ultrathin sections were further stained with 1% PAS for 30 min
at room temperature, washed with bidistilled water, and dried for another
30 min. Tannic acid staining was used to assess the presence or absence of
intracellular membranes (8).
Solid phase adhesion and invasion of cultured cells. Adherence of
various L. lactis strains to fibrinogen or fibronectin was conducted as previ-
ously described (24, 35, 47). In vitro cell internalization was assessed by sev-
eral methods. First, an antibiotic protection assay was performed as previ-
ously described using HUVECs and live bacteria (50, 51). 2 g/ml penicillin
or 100 g/ml gentamicin was used to kill noninternalized lactococci, and 20
mg/liter lysostaphin was used to kill noninternalized staphylococci. Results
were expressed as the percentage of surviving bacteria compared with S. au-
reus Cowan I (Table I). Second, the evaluation of invasion by flow cytome-
try was performed as previously described (8), with minor modifications.
Cells were plated in 24 wells at 1.5  105 cells, resulting in an estimated
multiplicity of infection of 35:1, and fluorescence values were normalized
to bacterial preparations of different species. Third, the confocal microscopy
study was performed in certain experiments to more clearly identify internal-
ization. Internalized FnBPA-positive lactococci were labeled with anti-FnBPA
antibodies after permeabilization using standard techniques.
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